Serum YKL-40: a New Potential Marker of Prognosis and Location of Metastases of Patients With Recurrent Breast Cancer

By Johansen J.S.   Cintin C.   Jorgensen M.   Kamby C.   Price P.A.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1437-1442

Elsevier

Access to resources Recommend Favorite

High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

By Choi In Keun   Kim Yeul Hong   Kim Jun Suk   Seo Jae Hong  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 861-864

Informa Healthcare

Access to resources Recommend Favorite

Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma

By                            

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3599-3606

Spandidos Publications

Access to resources Recommend Favorite

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients

By Nielsen Boye  

Clinical and Experimental Metastasis, Vol. 28, Iss. 1, 2011-01 ,pp. : 27-38

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

By Svane Inge   Pedersen Anders   Johansen Julia   Johnsen Hans   Nielsen Dorte   Kamby Claus   Ottesen Svend   Balslev Eva   Gaarsdal Eva   Nikolajsen Kirsten   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1485-1499

Springer Publishing Company

Access to resources Recommend Favorite